RESUMO
Bionanotechnology is considered a safe and ecofriendly route for the biosynthesis of metal nanoparticles from plant extracts, microorganisms, and biomaterials. The present study was focused on the fabrication of silver nanoparticles (<50 nm) biogenically from the novel Centratherum anthelmminticum's aqueous seed extract. The obtained nanoproduct was evaluated by X-ray diffraction analysis (XRD), Scanning electron microscopy (SEM), UV-Visible spectroscopy, FTIR and Raman spectroscopy. The particle size and surface charge were estimated by Dynamic light scattering (DLS) and Zeta potential measurements. The nanoparticles showed cubic close packed (ccp) morphology with miller indices (111), (200), (220), (311) and (222). The λmax for synthesized silver nanoparticles was measured in the range of 436 nm, 464 nm and 467 nm for 1 mM, 5 mM and 10 mM samples, respectively. The bioreduction of silver ions exhibited a gradual color change which confirms the formation of silver nanoparticles under UV-visible spectrum. Ag-O and Ag-N stretching vibrations corresponding to the bond formation between silver and oxygen of the carboxylate group and nitrogen of amine was corroborated by the presence of a sharp peak in Raman spectra at 245 cm-1. Antimicrobial activity was assessed against eight bacterial and three fungal strains. The silver nanoparticles fabricated from 10 mM AgNO3 solution showed significant results against all Gram-negative bacteria, with the further restriction in growth of C. albicans and A. niger. From in-vitro antimicrobial assay, it was observed that drug-loaded silver nanoparticles (Ciprofloxacin +10 mM) displayed a stronger potential than the synthesized silver nanoparticles and ciprofloxacin alone to restrain the development of E. coli, and E. aerogenes.